Total investments 16
Average round size 
$85M
The average size of a deal this fund participated in
Portfolio companies 11
Rounds per year 1.78
Lead investments 4
Follow on index
0.31How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees Soon
New York, New York, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of C-Bridge Capital:
Typical Co-investors
C-Bridge Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after C-Bridge Capital:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Atlantica Ventures | Lagos, Lagos, Nigeria |
| Beijing Xingchen Wenhua Chuanmei | Beijing, China, Pinggu |
| Beta Bridge Capital | New Jersey, Princeton, United States |
| CCFO Investments | Afghanistan, Kabul, Kabul Province |
| Crossroads Capital | Colorado, Greenwood Village, United States |
| DCapital | - |
| Huaou Equity Investment | China, Hangzhou, Zhejiang |
| Kunming Venture Capital | China, Kunming, Yunnan |
| New York Presbyterian Ventures | New York, New York, United States |
| Omron Ventures | Chiba, Japan, Minato |
| ProVen VCT | England, London, United Kingdom |
| Samsung Electronics | Seoul, Seoul-t'ukpyolsi, South Korea |
| Sintokogio | Aichi Prefecture, Japan, Nagoya |
| State Farm Ventures | Bloomington, Illinois, United States |
| Stonehenge Partners Inc. | Columbus, Ohio, United States |
| SuRo Capital | California, San Francisco, United States |
| Sustainable Performance Group | Mclean, United States, Virginia |
| TOM Capital Associates | Alberta, Calgary, Canada |
| TPG Biotech | California, San Francisco, United States |
| Yajie Shanghui | Beijing, China, Haidian |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
RVAC Medicines | $140M | 26 Apr 2022 | Singapore, Central Region, Singapore | ||
NiKang Therapeutics | $200M | 26 May 2021 | Wilmington, Delaware, United States | ||
Adcentrx Therapeutics | $50M | 28 Apr 2021 | San Diego, California, United States | ||
GrayBug | $80M | 20 Aug 2019 | Baltimore, Maryland, United States | ||
I-Mab Biopharma | $220M | 29 Jun 2018 | Shanghai | ||
| $20M | 28 Jun 2018 | Shanghai | |||
| $15M | 23 Apr 2018 | Jiang'an District, Hubei, China | |||
CMAB BioPharm | $34M | 02 Apr 2018 | Gusu District, Jiangsu, China | ||
CMAB BioPharm | $38M | 02 Jan 2018 | Gusu District, Jiangsu, China |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent C-Bridge Capital?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 16
Average round size 85M
Rounds per year 1.78
Peak activity year 2018
Lead investments 4
Follow on index 0.31
Exits 3
Group Appearance index 0.69
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
RVAC Medicines | $140M | 26 Apr 2022 | Singapore, Central Region, Singapore | ||
NiKang Therapeutics | $200M | 26 May 2021 | Wilmington, Delaware, United States | ||
Adcentrx Therapeutics | $50M | 28 Apr 2021 | San Diego, California, United States | ||
GrayBug | $80M | 20 Aug 2019 | Baltimore, Maryland, United States | ||
I-Mab Biopharma | $220M | 29 Jun 2018 | Shanghai | ||
| $20M | 28 Jun 2018 | Shanghai | |||
| $15M | 23 Apr 2018 | Jiang'an District, Hubei, China | |||
CMAB BioPharm | $34M | 02 Apr 2018 | Gusu District, Jiangsu, China | ||
CMAB BioPharm | $38M | 02 Jan 2018 | Gusu District, Jiangsu, China |
